| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SHPRH_0009000 | Intron-Exon | chr6:146240386-146254314 | chr6:145919250-145933178 | 128 nt | 0.4141 |
| hsa_SHPRH_0009300 | Exon-Exon | chr6:146240484-146242460 | chr6:145919348-145921324 | 302 nt | 0.4338 |
| hsa_SHPRH_0009400 | Exon-Exon | chr6:146240484-146248413 | chr6:145919348-145927277 | 144 nt | 0.4583 |
| hsa_SHPRH_0009500 | Exon-Exon | chr6:146240484-146254331 | chr6:145919348-145933195 | 283 nt | 0.4311 |
| hsa_SHPRH_0009600 | Exon-Exon | chr6:146240484-146263010 | chr6:145919348-145941874 | 1920 nt | 0.4495 |
| hsa_SHPRH_0009700 | Exon-Exon | chr6:146240484-146276490 | chr6:145919348-145955354 | 207 nt | 0.4251 |
| hsa_chr6_0217700 | Intergenic-Intergenic | chr6:146240588-146242457 | chr6:145919452-145921321 | 195 nt | 0.4103 |
| hsa_SHPRH_0009800 | Exon-Exon | chr6:146242303-146243972 | chr6:145921167-145922836 | 463 nt | 0.4233 |
| hsa_SHPRH_0009900 | Exon-Exon | chr6:146242428-146244921 | chr6:145921292-145923785 | 244 nt | 0.4344 |
| hsa_SHPRH_0010100 | Exon-Exon | chr6:146243422-146256577 | chr6:145922286-145935441 | 63 nt | 0.3492 |
A review of literature indicates that the circSHPRH is a tumor suppressor in brain cancer, specifically glioblastoma, where it is downregulated and its encoded SHPRH-146aa peptide inhibits glioma growth [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. A review of human studies indicates that the circSHPRH is downregulated in colorectal cancer tissues and is associated with metastasis and survival, while its overexpression inhibits proliferation and cell cycle progression [Lee et al. DOI:10.1016/j.biopha.2018.12.052].